Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Current Assets (2018 - 2026)

Alector's (ALEC) quarterly Current Assets came in at $180.1 million in Q2 2026, down 43.58% year-over-year from $319.2 million in Q2 2025, and down 16.27% quarter-over-quarter from $215.1 million in Q1 2026.

Analysis

Alector (ALEC) Current Assets (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Current Assets for 9 consecutive years, with $180.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets fell 43.58% year-over-year to $180.1 million in Q2 2026; TTM through Jun 2026 was $180.1 million, a 43.58% decrease from a year earlier, with the FY2025 full-year figure at $266.5 million, down 37.28% from the prior year.
  • Current Assets was $180.1 million for Q2 2026 at Alector, down from $215.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $890.9 million in Q1 2022 and troughed at $180.1 million in Q2 2026.
  • A 5-year average of $520.9 million and a median of $542.8 million in 2023 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets surged 151.12% in 2022 and slumped 43.58% in 2026, its largest moves.
  • Over 5 years, Current Assets stood at $726.4 million in 2022, then declined by 22.11% to $565.8 million in 2023, then decreased by 24.92% to $424.8 million in 2024, then sank by 37.28% to $266.5 million in 2025, then plunged by 32.41% to $180.1 million in 2026.
  • The last three Current Assets figures came in at $180.1 million (Q2 2026), $215.1 million (Q1 2026), and $266.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 8.07 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.62 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 7.31 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.63 Bn
10 Alector 274.68 Mn 101.88 Mn - 180.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 180.09 Mn
Mar 31, 2026 215.08 Mn
Dec 31, 2025 266.45 Mn
Sep 30, 2025 300.39 Mn
Jun 30, 2025 319.18 Mn
Mar 31, 2025 366.65 Mn
Dec 31, 2024 424.82 Mn
Sep 30, 2024 469.36 Mn
Jun 30, 2024 519.70 Mn
Mar 31, 2024 581.39 Mn
Dec 31, 2023 565.81 Mn
Sep 30, 2023 613.15 Mn
Jun 30, 2023 647.99 Mn
Mar 31, 2023 686.00 Mn
Dec 31, 2022 726.44 Mn
Sep 30, 2022 774.96 Mn
Jun 30, 2022 827.02 Mn
Mar 31, 2022 890.93 Mn
Dec 31, 2021 749.71 Mn
Sep 30, 2021 788.02 Mn